When was Millendo Therapeutics, Inc. stock made available for the first time to the public?

The IPO Date for Millendo Therapeutics, Inc. is 2012-10-04. On this 2012-10-04, Millendo Therapeutics, Inc. stock was made publicly available.

Where is the headquarters of Millendo Therapeutics, Inc. stock?

Headquarters of Millendo Therapeutics, Inc. is in US at 110 Miller Ave Ste 100, Ann Arbor, MI 48104.

What industry does Millendo Therapeutics, Inc. belong to?

The Millendo Therapeutics, Inc. belongs to Biotechnology.

Millendo Therapeutics, Inc.

MLND•NASDAQ

Healthcare

Biotechnology

$1.06

$-0.06(-5.36%)

Millendo Therapeutics, Inc. (MLND) Company Profile & Overview

Explore Millendo Therapeutics, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Millendo Therapeutics, Inc. (MLND) Company Profile & Overview

Millendo Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing novel treatments for orphan endocrine diseases in the United States. Its lead product candidates include livoletide, a potential treatment for Prader-Willi syndrome; nevanimibe, a potential treatment for patients with classic congenital adrenal hyperplasia; and MLE-301, a neurokinin 3-receptor antagonist for the treatment of vasomotor symptoms in menopausal women. The company is headquartered in Ann Arbor, Michigan.

SectorHealthcare

IndustryBiotechnology

CEODr. Julia Owens

Contact Information

http://www.millendo.com

17348459000

110 Miller Ave Ste 100, Ann Arbor, MI, 48104

Company Facts

12 Employees

IPO DateOct 4, 2012

CountryUS

Frequently Asked Questions

;